TMCnet News

Global Clinical Laboratory, Cardiac, Molecular Diagnostics and Genomic Testing Services Strategies & Trends 2017-2022 - Research and Markets
[September 25, 2017]

Global Clinical Laboratory, Cardiac, Molecular Diagnostics and Genomic Testing Services Strategies & Trends 2017-2022 - Research and Markets


The "Clinical Laboratory, Cardiac, Molecular Diagnostics and Genomic Testing Services. Strategies & Trends. Volume & Price Forecasts by Laboratory Department by Country. 2017 to 2022 - Global Version" report has been added to Research and Markets' offering.

"Clinical Laboratory, Cardiac, Molecular Diagnostics and Genomic Testing Services. Strategies & Trends. Volume & Price Forecasts by Laboratory Department 2017 to 2022 - Global Version" provides data that analysts and planners can use. Hundreds of pages of information including a complete list of Current 2017 United States Medicare Fee Payment Schedules to help sharpen your pricing. Make facilities planning decisions. Forecast demand for new testing regimes or technologies. Make research investment decisions.

A market that just keeps on growing. Clinical laboratory testing is positioned to directly benefit from the explosion in biotechnology, especially genomics. A range of dynamic trends are pushing market growth and company valuations.

Trends like:

  • changing demographics
  • emerging economies and global prosperity
  • biotechnology advances in genetics
  • healthcare expansion in China
  • climate change
  • gobalization
  • automation



Exciting technical developments especially in the area of molecular diagnostics and pharmacogenomics hold the promise of a dynamic, growing and evolving world market that is moving out of the national and regional orientation and onto a global stage.

Key Topics Covered:


1. Introduction and Market Definition

2. Overview of a Dynamic Market

3. Trends Driving a Changing Market

4. Laboratory, Molecular Diagnostics and Genomic Testing Recent Developments

5. Country Market Sizes - North America 2014 to 2022

6. Country Markets - Europe 2014 to 2022

7. Country Markets - Asia Pacific 2014 to 2022

8. Country Markets - Latin America, Africa & The Middle East 2014 to 2022

9. Global Market Summary 2014 to 2022

10. The Future of the Clinical Laboratory

Companies Mentioned

  • Abbott
  • Acibadem Labmed Laboratory
  • ACM Medical Laboratory
  • Adicon Clinical Laboratories
  • Alere
  • American Pathology Partners, Inc.
  • ARUP Laboratories, Inc.
  • Ascend Clinical, LLC
  • Aurora Diagnostics, LLC
  • Avant-Amarantus-Theranostics
  • B.P. CLINICAL LAB
  • Clarient, Inc.
  • Clinical Reference Laboratory, Inc.
  • Clongen Laboratories LLC
  • Dian Diagnostics
  • Exagen Diagnostics, Inc.
  • Forte Capital
  • Genomic Health, Inc.
  • Genzyme Corporation
  • Grail
  • Gribbles Pathology
  • Grifols
  • Hologic
  • Illumina
  • ImmuneHealth
  • Instrumentation Laboratory
  • Integrated Regional Laboratories, Inc.
  • Precipio Diagnostics
  • Professional Clinical Laboratory, Inc.
  • PSP
  • Psychemedics Corp.
  • Sonic Healthcare Limited
  • VCA Inc.
  • Viewics
  • Viracor Laboratories

For more information about this report visit https://www.researchandmarkets.com/research/4n73cw/clinical


[ Back To TMCnet.com's Homepage ]